Nova Patents
PL360406A1

Glucagon-like peptide-1 analogs

Abstract

Disclosed are glucagon-like peptide-1 (GLP-1) compounds with modifications at one or more of the following positions: 11, 12, 16, 22, 23, 24, 25, 27, 30, 33, 34, 35, 36, or 37. Methods of treating a subject in need of GLP-1 receptor stimulation using these GLP-1 compounds are also disclosed.

Term

Term ended

Projected expiry passed 1 June 2021, 5.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

66 members in 36 offices

This recordMember, by publication datePriority claim26 more offices are in the list below

Priority claims12

Priority claims
DocumentOfficeKindDate
21217100United States of AmericaP
21217100United States of AmericaP
24034900United States of AmericaP
24034900United States of AmericaP
0116474United States of AmericaW
0116474United States of AmericaW
0060212171
0060240349
01US0116474
US20000212171P
US20000240349P
WO2001US16474

Members66

Family members, oldest first
DocumentOfficeKind
CA2412004A1CanadaA1
DZ3388A1AlgeriaA1
WO0198331A2World Intellectual Property Organization (WIPO)A2
AU6479101AAustraliaA
PE20011363A1PeruA1
NO20025949D0NorwayD0
NO20025949LNorwayL
WO0198331A3World Intellectual Property Organization (WIPO)A3
KR20030009537ARepublic of KoreaA
ECSP024392AEcuadorA
EP1294757A2European Patent Office (EPO)A2
BR0111562ABrazilA
EA200300026A1Eurasian Patent Organization (EAPO)A1
CZ20024088A3CzechiaA3
MXPA02012203AMexicoA
SK17782002A3SlovakiaA3
IL153453D0IsraelD0
HU0301212A2HungaryA2
AR031701A1ArgentinaA1
US2003220243A1United States of AmericaA1
HK1055121A1Hong Kong, ChinaA1
CN1468258AChinaA
JP2004501162AJapanA
HRP20020996A2CroatiaA2
ZA200210098BSouth AfricaB
PL360406A1This recordPolandA1
HU0301212A3HungaryA3
NZ522330ANew ZealandA
US7084243B2United States of AmericaB2
EP1695983A2European Patent Office (EPO)A2
EP1294757B1European Patent Office (EPO)B1
AU2001264791B2AustraliaB2
US2006263849A1United States of AmericaA1
AT346093TAustriaT
DE60124710D1GermanyD1
EP1695983A3European Patent Office (EPO)A3
PT1294757EPortugalE
DK1294757T3DenmarkT3
ES2275685T3SpainT3
EA008837B1Eurasian Patent Organization (EAPO)B1
DE60124710T2GermanyT2
KR100847615B1Republic of KoreaB1
MY137350AMalaysiaA
US7498308B2United States of AmericaB2
EP1695983B1European Patent Office (EPO)B1
AT424413TAustriaT
CN100469791CChinaC
DE60137876D1GermanyD1
PT1695983EPortugalE
DK1695983T3DenmarkT3
ES2321439T3SpainT3
SI1695983T1SloveniaT1
IL153453AIsraelA
UA88862C2UkraineC2
TWI321134BTaiwan Province of ChinaB
EG24755AEgyptA
PL206302B1PolandB1
CA2412004CCanadaC
NO330686B1NorwayB1
JP4716641B2JapanB2
SK287757B6SlovakiaB6
HRP20020996B1CroatiaB1
CZ304002B6CzechiaB6
HU229108B1HungaryB1
HU229208B1HungaryB1
CY1109061T1CyprusT1